<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 2026 at 2:33 am by All in One SEO - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://www.nova-hub.com/default.xsl"?>

<rss version="2.0">
	<channel>
		<title>Nova Group</title>
		<link><![CDATA[https://www.nova-hub.com]]></link>
		<description><![CDATA[Nova Group]]></description>
		<lastBuildDate><![CDATA[2026-03-04T01:22:02+00:00]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<ttl>0</ttl>

		<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-jun-2024-2-2-2-2-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-jun-2024-2-2-2-2-2/]]></link>
			<title>Quarterly rpt on consolidated results for the financial period ended 31 Dec 2025</title>
			<pubDate><![CDATA[2026-03-04T01:22:02+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-ooi-keng-thye-4/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-ooi-keng-thye-4/]]></link>
			<title>Changes in Sub. S-hldr&#8217;s Int (Section 138 of CA 2016) &#8211; MR OOI KENG THYE</title>
			<pubDate><![CDATA[2026-01-29T05:52:13+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-ooi-keng-thye-3/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-ooi-keng-thye-3/]]></link>
			<title>Changes in Sub. S-hldr&#8217;s Int (Section 138 of CA 2016) &#8211; MR OOI KENG THYE</title>
			<pubDate><![CDATA[2026-01-29T05:51:59+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-ooi-keng-thye-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-ooi-keng-thye-2/]]></link>
			<title>Changes in Sub. S-hldr&#8217;s Int (Section 138 of CA 2016) &#8211; MR OOI KENG THYE</title>
			<pubDate><![CDATA[2026-01-29T05:51:36+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-ooi-keng-thye/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-ooi-keng-thye/]]></link>
			<title>Changes in Sub. S-hldr&#8217;s Int (Section 138 of CA 2016) &#8211; MR OOI KENG THYE</title>
			<pubDate><![CDATA[2026-01-14T02:12:37+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/co-founders-of-eyris-recognised-among-the-worlds-top-ophthalmology-scholars/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/co-founders-of-eyris-recognised-among-the-worlds-top-ophthalmology-scholars/]]></link>
			<title>CO-FOUNDERS OF EyRIS RECOGNISED AMONG THE WORLD’S TOP OPHTHALMOLOGY SCHOLARS</title>
			<pubDate><![CDATA[2026-01-14T01:41:49+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/annual-general-meeting-2-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/annual-general-meeting-2-2/]]></link>
			<title>General Meeting</title>
			<pubDate><![CDATA[2026-01-07T04:13:47+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/nova-eyris-presents-in-pacific-health-informatiion-network-phin-2025/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/nova-eyris-presents-in-pacific-health-informatiion-network-phin-2025/]]></link>
			<title>NOVA &#038; EyRIS SHOWCASE PROVEN SOLUTIONS IN PACIFIC HEALTH INFORMATION NETWORK (PHIN) 2025</title>
			<pubDate><![CDATA[2026-01-07T03:27:37+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/secondary-grading/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/secondary-grading/]]></link>
			<title>EyRIS Conducts Transfer-of-Knowledge for Secondary Grading in Brunei</title>
			<pubDate><![CDATA[2026-01-07T03:26:06+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/island-hospital-penang-awarded-flagship-medical-tourism-hospital-for-2025/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/island-hospital-penang-awarded-flagship-medical-tourism-hospital-for-2025/]]></link>
			<title>ISLAND HOSPITAL, PENANG AWARDED FLAGSHIP MEDICAL TOURISM HOSPITAL FOR 2025</title>
			<pubDate><![CDATA[2026-01-07T01:32:59+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/celebrating-excellence-in-quality-compliance/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/celebrating-excellence-in-quality-compliance/]]></link>
			<title>CELEBRATING EXCELLENCE IN QUALITY &#038; COMPLIANCE</title>
			<pubDate><![CDATA[2026-01-06T08:03:34+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/others-4/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/others-4/]]></link>
			<title>OTHERS</title>
			<pubDate><![CDATA[2025-12-23T03:27:37+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/general-meetings-outcome-of-meeting-18/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/general-meetings-outcome-of-meeting-18/]]></link>
			<title>GENERAL MEETINGS: Outcome of Meeting</title>
			<pubDate><![CDATA[2025-12-23T03:25:24+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/others-nova-msc-berhad-novamsc-or-the-company-dex-lab-pte-ltd-a-subsidiary-of-novamsc-appoints-sponsor-for-sgx-listing/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/others-nova-msc-berhad-novamsc-or-the-company-dex-lab-pte-ltd-a-subsidiary-of-novamsc-appoints-sponsor-for-sgx-listing/]]></link>
			<title>OTHERS NOVA MSC BERHAD (&#8220;NOVAMSC&#8221; OR THE &#8220;COMPANY&#8221;) Dex-lab Pte Ltd, a subsidiary of NOVAMSC, appoints Sponsor for SGX Listing</title>
			<pubDate><![CDATA[2025-12-02T06:28:24+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-jun-2024-2-2-2-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-jun-2024-2-2-2-2/]]></link>
			<title>Quarterly rpt on consolidated results for the financial period ended 30 Sep 2025</title>
			<pubDate><![CDATA[2025-12-02T06:22:58+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/others-nova-msc-berhad-novamsc-or-company-deviation-of-10-or-more-between-the-unaudited-and-audited-financial-statement-for-the-financial-period-ended-30-june-2025/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/others-nova-msc-berhad-novamsc-or-company-deviation-of-10-or-more-between-the-unaudited-and-audited-financial-statement-for-the-financial-period-ended-30-june-2025/]]></link>
			<title>OTHERS NOVA MSC BERHAD (&#8220;NOVAMSC&#8221; OR &#8220;COMPANY&#8221;) Deviation of 10% or More Between the Unaudited and Audited financial Statement for the Financial Period Ended 30 June 2025</title>
			<pubDate><![CDATA[2025-11-12T02:33:47+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/annual-report-cg-report-2025/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/annual-report-cg-report-2025/]]></link>
			<title>Annual Report &#038; CG Report &#8211; 2025</title>
			<pubDate><![CDATA[2025-11-12T02:27:08+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/audit-report-modified-opinion-material-uncertainty-related-to-going-concern-qualified-opinion/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/audit-report-modified-opinion-material-uncertainty-related-to-going-concern-qualified-opinion/]]></link>
			<title>AUDIT REPORT &#8211; MODIFIED OPINION / MATERIAL UNCERTAINTY RELATED TO GOING CONCERN : QUALIFIED OPINION</title>
			<pubDate><![CDATA[2025-11-12T02:26:25+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/general-meetings-notice-of-meeting-20/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/general-meetings-notice-of-meeting-20/]]></link>
			<title>General Meetings: Notice of Meeting</title>
			<pubDate><![CDATA[2025-11-10T08:53:55+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/corporate-governance-2-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/corporate-governance-2-2/]]></link>
			<title>Corporate Governance</title>
			<pubDate><![CDATA[2025-10-31T13:42:16+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/annual-reports/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/annual-reports/]]></link>
			<title>Annual Reports</title>
			<pubDate><![CDATA[2025-10-31T13:26:58+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/contact/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/contact/]]></link>
			<title>Contact Us</title>
			<pubDate><![CDATA[2025-10-16T07:48:23+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/national-dr-screening-project-showcased-at-civil-service-day-brunei-darussalam-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/national-dr-screening-project-showcased-at-civil-service-day-brunei-darussalam-2/]]></link>
			<title>NATIONAL DR SCREENING PROJECT SHOWCASED AT CIVIL SERVICE DAY, BRUNEI DARUSSALAM</title>
			<pubDate><![CDATA[2025-10-08T02:56:05+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/omans-national-diabetic-retinopathy-screening-programme-powered-by-eyris/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/omans-national-diabetic-retinopathy-screening-programme-powered-by-eyris/]]></link>
			<title>OMAN’S NATIONAL DIABETIC RETINOPATHY SCREENING PROGRAMME POWERED BY EYRIS</title>
			<pubDate><![CDATA[2025-10-08T02:39:11+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/eyris-founder-assoc-professor-daniel-ting-named-2024-young-scientist/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/eyris-founder-assoc-professor-daniel-ting-named-2024-young-scientist/]]></link>
			<title>EYRIS CO-FOUNDER ASSOC PROFESSOR DANIEL TING NAMED 2024 YOUNG SCIENTIST</title>
			<pubDate><![CDATA[2025-10-02T09:46:15+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/nova-showcasing-vesalius-at-international-hospital-expo-indonesia-2025/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/nova-showcasing-vesalius-at-international-hospital-expo-indonesia-2025/]]></link>
			<title>NOVA SHOWCASING VESALIUS AT INTERNATIONAL HOSPITAL EXPO, INDONESIA 2025</title>
			<pubDate><![CDATA[2025-09-25T06:12:58+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/the-sultanate-of-oman-launches-national-diabetic-screening-program-that-leverages-on-artificial-intellgence/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/the-sultanate-of-oman-launches-national-diabetic-screening-program-that-leverages-on-artificial-intellgence/]]></link>
			<title>THE SULTANATE OF OMAN LAUNCHES NATIONAL DIABETIC SCREENING PROGRAM THAT LEVERAGES ON ARTIFICIAL INTELLGENCE</title>
			<pubDate><![CDATA[2025-09-25T06:01:50+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/co-founder-of-eyris-elected-as-a-2025-fellow-of-royal-society/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/co-founder-of-eyris-elected-as-a-2025-fellow-of-royal-society/]]></link>
			<title>CO-FOUNDER OF EYRIS ELECTED AS A 2025 FELLOW OF ROYAL SOCIETY</title>
			<pubDate><![CDATA[2025-09-25T06:01:29+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/successful-pilot-of-selena-ai-diabetic-retinopathy-screening-in-myanmar/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/successful-pilot-of-selena-ai-diabetic-retinopathy-screening-in-myanmar/]]></link>
			<title>SUCCESSFUL PILOT OF SELENA+ AI DIABETIC RETINOPATHY SCREENING IN MYANMAR</title>
			<pubDate><![CDATA[2025-09-25T06:00:52+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-06-2025-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-06-2025-2/]]></link>
			<title>Consolidated results for the financial period ended 30/06/2025 (Amended Announcement)</title>
			<pubDate><![CDATA[2025-09-23T09:00:32+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-06-2025/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-06-2025/]]></link>
			<title>Quarterly rpt on consolidated results for the financial period ended 30/06/2025</title>
			<pubDate><![CDATA[2025-09-01T04:06:42+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/others-nova-msc-berhad-appointment-of-new-external-auditors/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/others-nova-msc-berhad-appointment-of-new-external-auditors/]]></link>
			<title>OTHERS NOVA MSC BERHAD &#8211; APPOINTMENT OF NEW EXTERNAL AUDITORS</title>
			<pubDate><![CDATA[2025-07-08T02:04:27+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-yam-tunku-nadzaruddin-ibni-almarhum-tuanku-jaafar-4/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-yam-tunku-nadzaruddin-ibni-almarhum-tuanku-jaafar-4/]]></link>
			<title>Changes in Sub. S-hldr&#8217;s Int (Section 138 of CA 2016) &#8211; YAM TUNKU NADZARUDDIN IBNI ALMARHUM TUANKU JA&#8217;AFAR</title>
			<pubDate><![CDATA[2025-07-08T01:49:48+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/notice-of-person-ceasing-section-139-of-ca-2016-raden-corporation-sdn-bhd/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/notice-of-person-ceasing-section-139-of-ca-2016-raden-corporation-sdn-bhd/]]></link>
			<title>Notice of Person Ceasing (Section 139 of CA 2016) &#8211; RADEN CORPORATION SDN BHD</title>
			<pubDate><![CDATA[2025-07-08T01:46:46+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/nova-msc-berhad-novamsc-or-the-company-resignation-of-auditors/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/nova-msc-berhad-novamsc-or-the-company-resignation-of-auditors/]]></link>
			<title>NOVA MSC BERHAD (&#8220;NOVAMSC&#8221; OR &#8220;THE COMPANY&#8221;) RESIGNATION OF AUDITORS</title>
			<pubDate><![CDATA[2025-06-24T07:54:49+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/change-in-boardroom-mr-lai-teik-kin-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/change-in-boardroom-mr-lai-teik-kin-2/]]></link>
			<title>Change in Boardroom &#8211; MR LAI TEIK KIN</title>
			<pubDate><![CDATA[2025-06-11T03:25:51+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-jun-2024-2-2-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/quarterly-rpt-on-consolidated-results-for-the-financial-period-ended-30-jun-2024-2-2-2/]]></link>
			<title>Consolidated results for the financial period ended 31 Mar 2025</title>
			<pubDate><![CDATA[2025-06-11T03:20:17+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/new-issue-of-securities-chapter-6-of-listing-requirements-fund-raising-7/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/new-issue-of-securities-chapter-6-of-listing-requirements-fund-raising-7/]]></link>
			<title>NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS) : FUND RAISING</title>
			<pubDate><![CDATA[2025-06-11T02:20:48+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-13/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-13/]]></link>
			<title>Changes in Director&#8217;s Interest (Section 219 of CA 2016) &#8211; MR LOH GUAN HUAT SUNNY</title>
			<pubDate><![CDATA[2025-06-11T02:17:54+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-loh-guan-huat-sunny/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-mr-loh-guan-huat-sunny/]]></link>
			<title>Changes in Sub. S-hldr&#8217;s Int (Section 138 of CA 2016) &#8211; MR LOH GUAN HUAT SUNNY</title>
			<pubDate><![CDATA[2025-06-11T02:17:21+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/change-in-financial-year-end/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/change-in-financial-year-end/]]></link>
			<title>Change in Financial Year End</title>
			<pubDate><![CDATA[2025-05-07T07:06:36+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/novanews/nova-awarded-automation-project-in-singapore/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/novanews/nova-awarded-automation-project-in-singapore/]]></link>
			<title>NOVA AWARDED AUTOMATION PROJECT IN SINGAPORE</title>
			<pubDate><![CDATA[2025-04-15T02:08:14+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-mr-lai-teik-kin-6/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-mr-lai-teik-kin-6/]]></link>
			<title>Changes in Director&#8217;s Interest (Section 219 of CA 2016) &#8211; MR LAI TEIK KIN</title>
			<pubDate><![CDATA[2025-04-09T09:15:23+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/dealings-in-listed-securities-chapter-14-of-listing-requirements-dealings-outside-closed-period-15/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/dealings-in-listed-securities-chapter-14-of-listing-requirements-dealings-outside-closed-period-15/]]></link>
			<title>DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period</title>
			<pubDate><![CDATA[2025-04-09T09:10:18+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-mr-lai-teik-kin-5/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-mr-lai-teik-kin-5/]]></link>
			<title>Changes in Director&#8217;s Interest (Section 219 of CA 2016) &#8211; MR LAI TEIK KIN</title>
			<pubDate><![CDATA[2025-04-09T09:06:16+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/additional-listing-announcement-subdivision-of-shares-168/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/additional-listing-announcement-subdivision-of-shares-168/]]></link>
			<title>Additional Listing Announcement /Subdivision of Shares</title>
			<pubDate><![CDATA[2025-04-09T09:01:05+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/additional-listing-announcement-subdivision-of-shares-167/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/additional-listing-announcement-subdivision-of-shares-167/]]></link>
			<title>Additional Listing Announcement /Subdivision of Shares</title>
			<pubDate><![CDATA[2025-04-09T08:58:42+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-mr-loh-guan-huat-sunny-2/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-mr-loh-guan-huat-sunny-2/]]></link>
			<title>Changes in Director&#8217;s Interest (Section 219 of CA 2016) &#8211; MR LOH GUAN HUAT SUNNY</title>
			<pubDate><![CDATA[2025-04-09T08:56:32+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-mr-loh-guan-huat-sunny/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-directors-interest-section-219-of-ca-2016-mr-loh-guan-huat-sunny/]]></link>
			<title>Changes in Director&#8217;s Interest (Section 219 of CA 2016) &#8211; MR LOH GUAN HUAT SUNNY</title>
			<pubDate><![CDATA[2025-04-09T08:53:15+00:00]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-13/]]></guid>
			<link><![CDATA[https://www.nova-hub.com/announcements/changes-in-sub-s-hldrs-int-section-138-of-ca-2016-13/]]></link>
			<title>Changes in Sub. S-hldr&#8217;s Int (Section 138 of CA 2016)</title>
			<pubDate><![CDATA[2025-04-09T08:49:57+00:00]]></pubDate>
		</item>
				</channel>
</rss>
